A detailed history of Oak Ridge Investments LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Oak Ridge Investments LLC holds 1,899 shares of VRTX stock, worth $899,708. This represents 0.08% of its overall portfolio holdings.

Number of Shares
1,899
Previous 1,915 0.84%
Holding current value
$899,708
Previous $779,000 1.8%
% of portfolio
0.08%
Previous 0.09%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 01, 2024

SELL
$407.69 - $446.08 $6,523 - $7,137
-16 Reduced 0.84%
1,899 $793,000
Q4 2023

Jan 16, 2024

SELL
$343.0 - $410.68 $10,976 - $13,141
-32 Reduced 1.64%
1,915 $779,000
Q3 2023

Oct 30, 2023

SELL
$338.18 - $362.46 $84,883 - $90,977
-251 Reduced 11.42%
1,947 $677,000
Q2 2023

Aug 07, 2023

BUY
$314.42 - $351.91 $691,095 - $773,498
2,198 New
2,198 $773,000
Q1 2021

May 04, 2021

SELL
$207.02 - $241.31 $3.1 Million - $3.61 Million
-14,968 Closed
0 $0
Q4 2020

Feb 03, 2021

SELL
$207.01 - $276.09 $1.25 Million - $1.66 Million
-6,027 Reduced 28.71%
14,968 $3.54 Million
Q3 2020

Nov 12, 2020

SELL
$255.65 - $303.1 $76,695 - $90,930
-300 Reduced 1.41%
20,995 $5.71 Million
Q2 2020

Aug 05, 2020

SELL
$225.48 - $295.8 $75,535 - $99,093
-335 Reduced 1.55%
21,295 $6.18 Million
Q1 2020

May 13, 2020

SELL
$199.77 - $247.81 $32,562 - $40,393
-163 Reduced 0.75%
21,630 $5.15 Million
Q4 2019

Feb 05, 2020

SELL
$166.71 - $223.91 $156,373 - $210,027
-938 Reduced 4.13%
21,793 $4.77 Million
Q3 2019

Nov 07, 2019

BUY
$166.23 - $187.09 $91,260 - $102,712
549 Added 2.47%
22,731 $3.85 Million
Q2 2019

Aug 14, 2019

SELL
$164.61 - $190.37 $447,245 - $517,235
-2,717 Reduced 10.91%
22,182 $4.07 Million
Q1 2019

May 09, 2019

BUY
$163.73 - $194.7 $4.08 Million - $4.85 Million
24,899 New
24,899 $4.58 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $122B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Oak Ridge Investments LLC Portfolio

Follow Oak Ridge Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oak Ridge Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Oak Ridge Investments LLC with notifications on news.